Where does Haus Bioceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Haus Bioceuticals, Inc. ranks #47,340 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Haus Bioceuticals, Inc. hold?

Haus Bioceuticals, Inc. holds 5 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Haus Bioceuticals, Inc.'s Innovation Score?

Haus Bioceuticals, Inc. has an Innovation Score of 18.9 out of 100 (5th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Haus Bioceuticals, Inc. focus on?

Haus Bioceuticals, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents, ranking #3,434 of 6,058 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Haus Bioceuticals, Inc.'s patent grant rate increasing or decreasing?

Haus Bioceuticals, Inc.'s recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Haus Bioceuticals, Inc.'s patents?

Haus Bioceuticals, Inc.'s patents average 9.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Haus Bioceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Haus Bioceuticals, Inc.

USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Haus ranks #47,340 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.

#47,340
of 49,997 US assignees by volume: 5th percentile
by Innovation Score (18.9/100): 9.4
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47340 · US Corporation #47,340 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,340/49,997
PHOTO-FINISH Has
CPC-NARROW A61P · 4 areas
INNOV-LOW 18.9/100
CLAIMS-PAR 9.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Has LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Haus’s 18.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (33%) Velocity 0.0 pts (0%) Breadth 7.1 pts (38%) Claim depth 5.6 pts (30%)

Qualcomm Incorporated · highest

85
Quarsa · near

19
Phoenix Conveyor… · near

19
Haus Bioceuticals · this assignee

19
Aribio · near

19
Ideal Fastener… · near

19
3D Lighting… · lowest

7

What this shows Haus's Innovation Score is 18.9/100 (5th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Haus?

Each dot is one of Haus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Haus’s own 9.4 claims/patent is at or below the 11.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Haus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Haus's grants concentrate

Haus Bioceuticals, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, Haus sits between Has LLC and Healionics Corporation.

Has

5
Hasport Performan…

5
Haul Hub

5
Haulerads

5
Hausman Properties

5
Hawa Valves (Indi…

5
Hawkeye Concrete…

5
Healionics

5
Haus Bioceuticals ◀

5

What this shows Haus holds 5 patents at rank #47,470, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Haus

By rank, the assignees closest to #47,470 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Haus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Haus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Haus ranks #3,434 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (19 here).

Phoenix Conveyor Belt Systems GmbH 19 Aribio Co., Ltd. 19 Quarsa, LLC 19 Ideal Fastener (GUANGDONG) Industries Ltd. 19

Haus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

19 5th percentile higher than 5% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Haus Bioceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	20.0%
2018	1	20.0%
2021	1	20.0%
2025partial year	2	40.0%

Which technologies does Haus Bioceuticals, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

Y02A - Technologies FOR Adaptation TO Climate Change 2

C07K - Peptides 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Haus Bioceuticals, Inc.'s patent record in context - here's where to go next.

Haus Bioceuticals, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #47,340 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Haus Bioceuticals, Inc. against Has LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 18.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.